Medical specialists from India tagged as investigators in clinical trials studying Infections

Total 39 results

Sanjeev Sinha, MD
Seen in:
- Delhi, New Delhi, All India Institute of Medical Sciences
- New Delhi, All India Institute of Medical Sciences, New Delhi
Trials:
- NCT00692809 (Sub-Investigator)
- NCT02016638 (Sub-Investigator)
Conditions:
Sharmila A. Pimple
Seen in:
- Mumbai, Tata Memorial Hospital
Trials:
- NCT04142398 (Principal Investigator)
- NCT04142385 (Principal Investigator)
Conditions:
Siddharth Dubhashi
Seen in:
- Nagpur, GSK Investigational Site
Trials:
- NCT04420221 (Principal Investigator)
Conditions:
- Infections, Soft Tissue
Smita Nagpal
Seen in:
- Gujarat, Ahmedabad, GSK Investigational Site
Trials:
- NCT04420221 (Principal Investigator)
Conditions:
- Infections, Soft Tissue
Subash Babu, MBBS, PhD
Seen in:
- Tamilnadu, Chennai, National Institute for Research in Tuberculosis
Trials:
- NCT04930978 (Principal Investigator)
- NCT04642755 (Principal Investigator)
- NCT04844242 (Principal Investigator)
Conditions:
Surendra K Sharma, M.D., Ph.D
Seen in:
- Delhi, New Delhi, All India Institute of Medical Sciences
Trials:
- NCT00692809 (Principal Investigator)
Conditions:
Venkatesh Prajna
Seen in:
- Tamil Nadu, Madurai, Aravind Eye Hospital
Trials:
- NCT01560208 (Principal Investigator)
Conditions:
- Corneal Ulcer
Vijay Nair
Seen in:
- Mumbai, Udaan Trust
Trials:
- NCT04142398 (Principal Investigator)
- NCT04142385 (Principal Investigator)
Conditions:
Yogesh Sharma
Seen in:
- Maharashtra, Thane, GSK Investigational Site
Trials:
- NCT04420221 (Principal Investigator)
Conditions:
- Infections, Soft Tissue

Clinical Trials on Infections

International Centre for Diarrhoeal Disease Research...
Centers for Disease Control and Prevention

Not yet recruiting

Co-administration Study of OCV, TCV and MR

Measles | Rubella | Cholera | Typhoid
MJM Bonten
Janssen Research & Development, LLC; Innovative Medicines Initiative

Completed

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1) (EXPECT-1)

E.Coli Infections

United States, United Kingdom, Canada, France, Germany, Italy, Japan, Spain
University of Pittsburgh

Withdrawn

Ampicillin-sulbactam Resistant E.Coli at UPMC

Positive E Coli Infections

United States
Pfizer

Completed

Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants

Group B Streptococcus Infections

United States, South Africa, United Kingdom
GlaxoSmithKline

Active, not recruiting

A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants

Infections, Meningococcal

Finland, Poland, Spain, United Kingdom, Germany, South Africa, Dominican Republic, Israel, Honduras
Pfizer

Completed

Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine

Infections, Meningococcal

Australia, Canada, Czechia, Panama, South Africa, Turkey
GlaxoSmithKline

Completed

Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old Children

Infections, Meningococcal

Finland
Pfizer

Completed

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Infections, Meningococcal

Philippines
GlaxoSmithKline

Completed

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

Infections, Meningococcal

United States, Finland, Poland
Pfizer

Completed

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

Infections, Meningococcal

Finland

Medical specialists from India tagged as investigators in clinical trials studying Infections

Clinical Trials on Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations